NASDAQ: ITCI - Intra-Cellular Therapies, Inc.

Yield per half year: +29.46%
Sector: Healthcare

Share chart Intra-Cellular Therapies, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Intra-Cellular Therapies, Inc., биофармацевтическая компания, разрабатывает новые препараты для лечения психоневрологических и неврологических заболеваний и других заболеваний центральной нервной системы (ЦНС) в США. Компания разрабатывает свой ведущий кандидат на лекарство CAPLYTA для лечения шизофрении, биполярного расстройства, поведенческих нарушений, связанных с деменцией, аутизмом и другими заболеваниями ЦНС.

More details
Также разрабатывается ITI-002, который ингибирует фермент фосфодиэстеразу типа 1; ITI-214 для болезни Паркинсона; и ITI-333 для расстройств, связанных с употреблением психоактивных веществ, боли и сопутствующих психических заболеваний, включая депрессию и тревогу. Головной офис Intra-Cellular Therapies, Inc. находится в Нью-Йорке, штат Нью-Йорк.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/S 28379.29
P/BV 8.82
EV/EBITDA -10.65
EBITDA -0.1535
Цена ао 85.47
Сайт https://www.intracellulartherapies.com
Число акций ао 0.09588 млрд
Выручка 6.1E-5
Див.доход ао 0
ISIN US46116X1019
Валюта usd
IPO date 2014-01-07
Sector Health Care
Industry Pharmaceuticals
Валюта отчета usd
Change price per day: 0% (84.99)
Change price per week: +1.97% (83.35)
Change price per month: +12.11% (75.81)
Change price per 3 month: +16.79% (72.77)
Change price per half year: +29.46% (65.65)
Change price per year: +62.38% (52.34)
Change price per 3 year: +62.38% (52.34)
Change price per 5 year: +281.81% (22.26)
Change price per 10 year: +419.82% (16.35)
Change price per year to date: +20.57% (70.49)
All parameters

Underestimation

Title Value Grade
P/S 14.59 1
P/BV 11.41 1
P/E 0 0
EV/EBITDA -41.64 0
Total: 1.88

Efficiency

Title Value Grade
ROA, % -19.18 0
ROE, % -23.62 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1066 10
Total: 7.8

Growth impulse

Title Value Grade
Yield Revenue, % 757563.93 10
Yield Ebitda, % 3.15 1
Yield EPS, % -45.64 0
Total: 2.2
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
23.08.2024 23.08.2024 Mates Sharon
Officer		 Purchase 74.4 2 133 790 28680 0 0.04 link
24.06.2024 25.06.2024 RIGGS RORY B
Director		 Sale 75.57 337 193 4462 0 -0.01 link
24.06.2024 25.06.2024 RIGGS RORY B
Director		 Purchase 16.86 337 200 20000 0 0.02 link
26.02.2024 27.02.2024 Durgam Suresh K.
EVP, Chief Medical Officer		 Sale 70.17 288 539 4112 0 -0.01 link
26.02.2024 27.02.2024 Hineline Lawrence J.
SVP of Finance, CFO		 Sale 69.43 925 988 13337 0 -0.02 link
26.02.2024 27.02.2024 Hineline Lawrence J.
SVP of Finance, CFO		 Purchase 36.89 216 987 5882 0 0.01 link
26.02.2024 27.02.2024 Halstead Michael
EVP and General Counsel		 Sale 69.53 549 774 7907 0 -0.01 link
11.01.2024 12.01.2024 Halstead Michael
EVP and General Counsel		 Sale 66.83 3 341 500 50000 0 -0.06 link
11.01.2024 12.01.2024 Halstead Michael
EVP and General Counsel		 Purchase 13.6 680 000 50000 0 0.06 link
28.03.2023 30.03.2023 Neumann Mark
EVP, Chief Commercial Officer		 Sale 54.31 847 453 15604 0 -0.02 link
13.03.2023 13.03.2023 Mates Sharon
Chairman, President & CEO		 Sale 44.99 925 219 20565 0 -0.03 link
13.03.2023 13.03.2023 Mates Sharon
Chairman, President & CEO		 Purchase 3.26 65 200 20000 0 0.02 link
13.03.2023 13.03.2023 Hineline Lawrence J.
SVP of Finance CFO		 Sale 44.93 250 799 5582 0 -0.01 link
13.03.2023 13.03.2023 Halstead Michael
EVP and General Counsel		 Sale 44.94 330 039 7344 0 -0.01 link
13.03.2023 13.03.2023 Neumann Mark
EVP, Chief Commercial Officer		 Sale 44.98 169 035 3758 0 0 link
13.03.2023 13.03.2023 Durgam Suresh K.
EVP, Chief Medical Officer		 Sale 45.04 330 774 7344 0 -0.01 link
10.03.2023 13.03.2023 Mates Sharon
Chairman, President & CEO		 Sale 43.15 1 802 380 41770 0 -0.05 link
10.03.2023 13.03.2023 Hineline Lawrence J.
SVP of Finance CFO		 Sale 43.06 674 449 15663 0 -0.02 link
10.03.2023 13.03.2023 Halstead Michael
EVP and General Counsel		 Sale 43.1 720 115 16708 0 -0.02 link
10.03.2023 13.03.2023 Neumann Mark
EVP, Chief Commercial Officer		 Sale 43.34 370 557 8550 0 -0.01 link
21.09.2022 23.09.2022 Hineline Lawrence J.
SVP of Finance CFO		 Sale 45.63 2 973 430 65164 0 -0.08 link
21.09.2022 23.09.2022 Hineline Lawrence J.
SVP of Finance CFO		 Purchase 15.47 1 008 090 65164 0 0.08 link
04.03.2022 04.03.2022 Durgam Suresh K.
Chief Medical Officer		 Sale 55.52 214 307 3860 0 0 link
02.03.2022 04.03.2022 Durgam Suresh K.
Chief Medical Officer		 Sale 56.98 238 005 4177 0 -0.01 link

Institutions Volume Share, %
FMR, LLC 11457694 11.84
Vanguard Group Inc 9094302 9.39
Blackrock Inc. 8193544 8.46
Wasatch Advisors LP 3627308 3.75
Bellevue Group AG 3066400 3.17
Avoro Capital Advisors LLC 2255555 2.33
State Street Corporation 2220850 2.29
JP Morgan Chase & Company 2072615 2.14
Geode Capital Management, LLC 2001791 2.07
Deep Track Capital, LP 2000000 2.07

ETF Share, % Profitability for 1 year, % Dividends, %
PSYK ETF 6.54
iShares Neuroscience and Healthcare ETF 3.99412 19.720292847757 0.03
AdvisorShares Psychedelics ETF 4.59804 845.98540145985 0.20
iShares U.S. Pharmaceuticals ETF 2.94832 19.78048362202 1.97922
SPDR S&P Pharmaceuticals ETF 3.60054 29.798803697662 1.29889
Virtus LifeSci Biotech Products ETF 1.63006 36.788704846892 0.13953
Principal Healthcare Innovators ETF 0.79497 618.4964157054 0.8416
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 2.9373 86.715867158672 1.2989
First Trust NYSE Arca Biotechnology Index Fund 3.08817 -86.982091952343 0.26101
First Trust Active Factor Small Cap ETF 0.24808 34.251150665961 1.61948
Avantis U.S. Equity ETF 0.00854 30.365392144069 1.59151
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.1985 30.938355271732 1.42082
ProShares Ultra Nasdaq Biotechnology 0.52397 51.697637072723 0.85651
ProShares UltraShort Nasdaq Biotechnology 0.21 -40.363937138131 1.76
BNY Mellon US Mid Cap Core Equity ETF 0.20803 30.412321007464 1.5641
Dimensional U.S. Core Equity 2 ETF 0.00173 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.00356 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00358 31.530984204131 1.3557
Invesco Russell 1000 Equal Weight ETF 0.07956 23.843503937008 2.1901
Vanguard ESG U.S. Stock ETF 0.02 32.395678092399 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.14308 31.110458284371 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.09243 41.560262822399 1.02425
Fidelity Growth Opportunities ETF 0.24923 19.43767360127 0.48881
Fidelity MSCI Health Care Index ETF 0.10802 16.20294599018 1.46057
RiverNorth Patriot ETF 0.38022 29.660107334526 2.28129
First Trust Mid Cap Core AlphaDEX Fund 0.15407 32.157409393095 1.65423
First Trust Mid Cap Growth AlphaDEX Fund 0.30692 39.290639813144 0.9035
First Trust Nasdaq Pharmaceuticals ETF 0.52071 18.366517675742 2.19901
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.01318 32.996534978682 1.42661
Humankind US Stock ETF 0.03372 18.809430395549 1.99919
Hartford Longevity Economy ETF 0.18732 25.005998560346 1.53371
Invesco Nasdaq Biotechnology ETF 0.78865 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.16384 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.32477 33.628071953382 0.72598
Inspire Small/Mid Cap ETF 0.2052 28.6475145255 1.92038
iShares Russell 1000 Growth ETF 0.02923 35.669556840077 0.68889
iShares Russell Mid-Cap Growth ETF 0.28594 40.641877856253 0.69551
iShares Russell Midcap ETF 0.06858 33.221757322176 1.71565
iShares Russell 3000 ETF 0.0147 31.230028873917 1.43482
iShares Dow Jones U.S. ETF 0.01441 31.213924963925 1.41797
John Hancock Multifactor Mid Cap ETF 0.05694 29.665565648225 1.52586
John Hancock Multifactor Small Cap ETF 0.4976 29.343594166631 1.54912
iShares Morningstar Small-Cap ETF 0.16384 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.32477 682.83677107207 0.72598
First Trust Multi-Manager Small Cap Opportunities ETF 0.30233 48.514285714286 0.31756
Simplify Health Care ETF 0.93458 27.811678483231 1.00373
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02947 32.025164769323 1.75869
QRAFT AI Enhanced U.S. Large Cap ETF 0.06209 31.155018846182 1.25914
Hartford Multifactor US Equity ETF 0.03992 28.958733205374 1.92094
Schwab U.S. Small-Cap ETF 0.19814 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.01362 32.5 1.43354
Schwab 1000 Index ETF 0.01424 -34.268125854993 1.42441
Schwab US Mid-Cap ETF 0.17337 -57.773902935193 1.59098
SoFi Next 500 ETF 0.37751 29.558208955224 1.43041
iShares Russell 2500 ETF 0.12623 30.434782608696 1.58987
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.07876 27.432590855803 1.66828
SPDR Portfolio MSCI Global Stock Market ETF 0.02433 23.658352229781 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.02246 32.126302235749 1.69572
Vanguard Russell 1000 ETF 0.01 31.060019361084 1.43539
Vanguard Russell 1000 Growth ETF 0.03 36.375767280491 0.68737
Vanguard Russell 3000 ETF 0.01 31.87314172448 1.43817
Vanguard Extended Market ETF 0.1 39.61241360618 1.34786
Future Tech ETF 0.79497 426.33969118983 0.8416



Head Job title Payment Year of birth
Mr. Michael I. Halstead J.D. President 983.65k 1973 (51 year)
Dr. Suresh K. Durgam M.D. Executive VP & Chief Medical Officer 961.84k 1969 (55 years)
Mr. Mark Neumann EVP & Chief Commercial Officer 998.36k 1963 (61 year)
Mr. Juan Fernando Sanchez Vice President of Corporate Communications & Investor Relations 296.75k 1971 (53 years)
Ms. Karen Patruno Sheehy Esq. Senior VP & Chief Compliance Officer N/A 1962 (62 years)
Dr. Michael Olchaskey Senior VP & Head of Regulatory Affairs N/A
Mr. John A. Bardi Senior VP of Market Access, Policy & Government Affairs N/A
Dr. Robert E. Davis Ph.D. Senior VP & Chief Scientific Officer 646.12k 1951 (73 years)
Dr. Sharon Mates Ph.D. Co-Founder, Chairman & CEO 2.23M 1953 (71 year)
John P. Condon Senior Vice President, General Counsel & Secretary

Address: United States, New York, NY , 430 East 29th Street - open in Google maps, open in Yandex maps
Website: https://www.intracellulartherapies.com